Product nameAnti-TNFAIP8L1/TIPE1 antibody
DescriptionRabbit polyclonal to TNFAIP8L1/TIPE1
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat, Horse, Chicken, Cow, Cat, Dog
Synthetic peptide corresponding to Human TNFAIP8L1/TIPE1 aa 136-185 (internal sequence).
Database link: NP_689575
- HepG2 Cell lysate
This product was previously labelled as TNFAIP8L1
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
Storage bufferPreservative: 0.09% Sodium azide
Constituents: 2% Sucrose, PBS
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab85409 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 1 mg/ml. Predicted molecular weight: 21 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.|
RelevanceTNFAIP8L1 belongs to the TNFAIP8 family. The exact function of TNFAIP8L is not known.
- MGC17791 antibody
Anti-TNFAIP8L1/TIPE1 antibody (ab85409) at 1 µg/ml + HepG2 Cell lysate at 10 µg
HRP conjugated anti-Rabbit IgG at 1: 50,000
Predicted band size: 21 kDa
Observed band size: <22 kDa why is the actual band size different from the predicted?
Gel concentration: 12%
This product has been referenced in:
- Chen P et al. TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration. Clin Transl Oncol 21:334-341 (2019). Read more (PubMed: 30062520) »
- Hu W et al. TIPE1 Inhibits Breast Cancer Proliferation by Downregulating ERK Phosphorylation and Predicts a Favorable Prognosis. Front Oncol 9:400 (2019). Read more (PubMed: 31179241) »